Skip to content

Role of Peripheral Vision in Scene Perception (PERISCE)

Role of Peripheral Vision in Scene Perception

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05539508
Acronym
PERISCE
Enrollment
120
Registered
2022-09-14
Start date
2022-10-01
Completion date
2027-07-01
Last updated
2022-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary Open-angle Glaucoma (POAG)

Brief summary

Despite its low spatial resolution, peripheral vision is very useful for rapidly categorizing a visual scene. Low spatial frequencies of a visual stimulus available in peripheral vision would allow a coarse categorization of the scene and objects (deciding, for example, whether it is an urban or natural landscape). This first representation would then trigger predictive mechanisms which would subsequently guide a more detailed visual analysis in central vision. The psychophysical studies that the investigators have already conducted in this scientific context has been carried out under normal vision conditions. The objective of this project is to study the influence of peripheral vision on central vision with an original approach: What are the consequences of a loss of peripheral vision on the processing performed in central vision? The project will concern patients with glaucoma. This ophthalmic pathology particularly affects the peripheral retina and thus represents a good pathological cognitive model of a visual recognition system in which peripheral vision is less important. The investigators will conduct psychophysical studies with glaucomatous patients and healthy volunteers with normal vision. All participants will be required to perform a short experiment on a computer (15 minutes) where they will look at different photographs of scenes of different luminance and spatial frequencies. Participants will have to perform various tasks on these images using the keys on the keyboard.

Interventions

BEHAVIORALPsychophysical evaluation

All participants will be required to perform a short experiment on a computer (15 minutes) where they will look at different photographs of scenes of different luminance and spatial frequencies. They will have to perform various tasks on these images using the keys on the keyboard.

Sponsors

University Hospital, Grenoble
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

For patients : * between 18 and 80 years old * stable bilateral primary open angle glaucoma (POAG) * visual acuity \> 5/10 for distant vision for the eye tested * peripheral visual field defect on the eye tested measured through a Humphrey Visual Field Analyzer For healthy volunteers : * between 18 and 80 years old * visual acuity \> 5/10 * absence of ophthalmologic disease other than Glaucoma (age-related macular degeneration, cataract except for uncomplicated cataract surgery, amblyopia, optic neuropathy, diabetic retinopathy …)

Exclusion criteria

* ophthalmologic disease other than Glaucoma (age-related macular degeneration, cataract except for uncomplicated cataract surgery, amblyopia, optic neuropathy, diabetic retinopathy …) * treated with medication that might compromise sustained attention (benzodiazepine, narcoleptics)

Design outcomes

Primary

MeasureTime frameDescription
Psychophysical measure : Percentage of correct responseThrough study completion of 45 monthsMeasure calculated by the comparison between the expected response and the response provided by the participant for each trial of the experiment
Psychophysical measure : Mean reaction time in millisecondsThrough study completion of 45 monthsMeasure calculated by averaging the time in milliseconds taken by the participant to provide the response for each trial of the experiment

Contacts

Primary ContactCarole Peyrin, PhD
carole.peyrin@univ-grenoble-alpes.fr04 76 82 58 79

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026